PMID: 15332546Aug 31, 2004Paper

A case of recurrent pulmonary lymphoepithelioma-like carcinoma responding to treatment with CBDCA/paclitaxel combined chemotherapy

Gan to kagaku ryoho. Cancer & chemotherapy
Tetsuya AbeFumitake Gejyo

Abstract

A 57-year-old female underwent left lower lung lobectomy and was histologically diagnosed as having lymphoepithelioma-like carcinoma. One year and 2 months after surgery, pleural thickening was recognized, so she was administered 4 courses of CBDCA/PTX combined chemotherapy. Toxicity associated with the chemotherapy was very mild. Pleural thickening and effusion disappeared after treatment, so this case was judged to be a complete response. She suffered from left chest pain before chemotherapy, which later lessened. She was thus able to stop taking NSAIDs. Because primary pulmonary lymphoepithelioma-like carcinoma is a rare tumor, there is no standard chemotherapy treatment. CBDCA/PTX combined chemotherapy is effective for pulmonary lymphoepithelioma-like carcinoma and shows good tolerability and improves QOL.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Asian Cardiovascular & Thoracic Annals
Neerod Kumar JhaJohn Stubberfield
International Journal of Urology : Official Journal of the Japanese Urological Association
T InoueO Yoshida
Gan to kagaku ryoho. Cancer & chemotherapy
Kenta FurukawaHiroaki Nagano
Actas urologicas españolas
J M Abascal JunqueraJ Morote Robles
© 2021 Meta ULC. All rights reserved